KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) will release earnings results for the first quarter before the opening bell on Thursday, Sept. 11.
Analysts expect the Cambridge, Massachusetts-based company to report a quarterly loss at 96 cents per share, versus a year-ago loss of 87 cents per share. KalVista Pharmaceuticals projects to report quarterly revenue of $2.09 million, according to data from Benzinga Pro.
On Aug. 11, KalVista Pharmaceuticals announced maintenance of Orphan Designation for Sebetralstat in the European Union.
KalVista Pharmaceuticals shares fell 2.2% to close at $15.61 on Tuesday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have …